NASDAQ: NNNN
Anbio Biotechnology Stock Ownership - Who owns Anbio Biotechnology?

Insider buying vs selling

Have Anbio Biotechnology insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when NNNN insiders and whales buy or sell their stock.

NNNN Shareholders

What type of owners hold Anbio Biotechnology stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Marshall Wace LLP0.03%43,629$377.83kInstitution
Geode Capital Management LLC0.01%17,060$147.74kInstitution
Ubs Group Ag0.00%5,738$49.69kInstitution
Concourse Financial Group Securities Inc0.00%0$0.00Institution

1 of 1

NNNN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NNNN0.05%0.00%
GPCR32.40%12.52%
CVAC3.50%0.00%
LQDA44.72%55.28%Net BuyingNet Selling
TVTX62.84%37.16%Net SellingNet Selling

Anbio Biotechnology Stock Ownership FAQ

Who owns Anbio Biotechnology?

Anbio Biotechnology (NASDAQ: NNNN) is owned by 0.05% institutional shareholders, 0.00% Anbio Biotechnology insiders, and 99.95% retail investors. Marshall Wace LLP is the largest individual Anbio Biotechnology shareholder, owning 43,629.00 shares representing 0.03% of the company. Marshall Wace LLP's Anbio Biotechnology shares are currently valued at $377.83k.

If you're new to stock investing, here's how to buy Anbio Biotechnology stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.